Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-Term Extension of hGH in Adult Growth Hormone Deficiency
NCT00184730Phase 3Completed
- Sponsor
- Novo Nordisk
- Start
- Nov 2004
- Primary completion
- Sep 2006
- Modality
- Hormone, rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
A Phase 3 trial of somatropin in adult growth hormone deficiency (AGHD), sponsored by Novo Nordisk. Started Nov 2004; status: completed.
02
Drugs
somatropin
03
Conditions
adult growth hormone deficiency (AGHD)
Beyond the preview
Go deeper on NCT00184730.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00184730.